Novel inhibitor of nucleoside hydrolase (NH)

The first reported BoNT/E small molecule inhibitor

Novel inhibitor of lipid metabolism, disrupting tubulin polymerization,suppressing monoglycerol metabolism depleting lipids and inhibiting the growth of both lymphoma and RCC both in vitro and in vivo

Novel inhibitor of poly (ADP-ribose) polymerase-1 (PARP-1)

Telomerase inhibitor, anticancer agent

Telomerase inhibitor, stabilizing G-quadruplex and suppressing cell growth of A549 human lung cancer cells through activation of the ATR/Chk1-dependent pathway

Novel down-regulator of EZH2, inducing G2/M cell-cycle arrest of cancer cells and degradating p53 via proteasome-dependent and -independent pathways

Novel anticancer agent, suppressing the growth of several cell lines derived from lung, colon, breast, ovarian, and kidney cancers

Cytotoxic MDR-selective ligand

Novel Inhibitor of HCV NS3/4A Proteinase

Novel Inhibitor of HCV NS3/4A Proteinase

Novel selective serotonin reuptake inhibitor (SSRI), exhibiting higher binding affinities in comparison with the paroxetine

Novel Inhibitor of HCV NS3/4A Proteinase

Novel inhibitor of the Skp2-Cks1 protein-protein interaction and p27Kip1 ubiquitination in vitro

Novel inhibitor of the Skp2-Cks1 protein-protein interaction and p27(Kip1) ubiquitination in vitro

Novel NF-κB inhibitor

Potent and selective nociceptin opioid receptor (NOP) agonist

Potent CDC25A>Cdc25A inhibitor; Vitamine K3 analogue

Toxitant of Saccharomyces_cerevisiae>Saccharomyces cerevisiae

IκBα phosphorylation inhibitor

Novel potent inhibitor of Huntington's disease (HD) pathogenesis via targeting CAG repeats RNA and Poly Q protein

Novel dual inhibitor of viral and Streptococcus pneumoniae neuraminidase

Novel selective non-zinc-binding MMP-2 inhibitor

Novel inhibitor of ABCG2 transporter function

Novel DNA repair inhibitor

Novel activator of lanthionine synthetase C-like 2 (LANCL2), down-modulating pulmonary inflammation through the downregulation of TNF-α and MCP-1 and reduction in the infiltration of neutrophils, accelerating recovery and inducing IL-10-mediated regulator

Novel efflux pump inhibitor (EPI)

Novel non-peptide disruptor of IKKß/NEMO complex

Novel potent SHP2 Inhibitor with Anti-Proliferative Activity in Breast Cancer Cell Lines

Novel antagonist of the Grb7 SH2 domain; Antitumor Agent